Falsolieva Fulvestrant Injection 250mg

Falsolieva Fulvestrant Injection 250mg Description:

Falsolieva Fulvestrant Injection 250mg is a medication used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is a selective estrogen receptor down regulator (SERD) that works by binding to estrogen receptors on cancer cells, leading to the degradation of the receptors and reducing estrogen’s ability to stimulate cancer growth. Fulvestrant is typically administered as an intramuscular injection and is used when cancer is not responding to other hormonal therapies.

Uses:

• Breast Cancer Treatment: Fulvestrant is mainly used to treat hormone receptor-positive breast cancer in postmenopausal women. It is often used in cases where the cancer has progressed despite prior treatments such as tamoxifen or aromatase inhibitors.
• Metastatic Cancer: It is used for the treatment of metastatic breast cancer, which has spread beyond the original site.
• Combination Therapy: Fulvestrant can be used alone or in combination with other medications, such as CDK4/6 inhibitors, for enhanced therapeutic efficacy.

Side Effects:

Common side effects of Fulvestrant Injection 250 mg may include:

• Injection site reactions: Pain, redness, or swelling at the site of injection.
• Fatigue: Feeling tired or weak, which is common with cancer treatments.
• Hot flashes: A common symptom due to the hormonal changes caused by Fulvestrant.
• Nausea and Vomiting: Some patients may experience digestive upset, though it’s usually mild.
• Headaches: Fulvestrant may cause headaches in some patients.
• Bone Pain: Joint or bone pain, particularly in patients with metastatic cancer.

Dosage:

Your doctor or nurse will give you this medicine. Kindly do not self administer.